WO2002067939A1 - Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function - Google Patents
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Download PDFInfo
- Publication number
- WO2002067939A1 WO2002067939A1 PCT/US2002/005302 US0205302W WO02067939A1 WO 2002067939 A1 WO2002067939 A1 WO 2002067939A1 US 0205302 W US0205302 W US 0205302W WO 02067939 A1 WO02067939 A1 WO 02067939A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isoindole
- dione
- tetrahydro
- substituted
- hexahydro
- Prior art date
Links
- 0 *C(*)(C(CC1)[C@@]2(*3)C(*4c5cc(N)cc(N)c5)=O)C1[C@]23C4=O Chemical compound *C(*)(C(CC1)[C@@]2(*3)C(*4c5cc(N)cc(N)c5)=O)C1[C@]23C4=O 0.000 description 2
- ISGDBJPWHHXRFG-UHFFFAOYSA-N CC[n]1c(cc(C)cc2)c2c2ccccc12 Chemical compound CC[n]1c(cc(C)cc2)c2c2ccccc12 ISGDBJPWHHXRFG-UHFFFAOYSA-N 0.000 description 1
- FRLVKAJKOYFHKQ-UHFFFAOYSA-N Cc(cc1)c(cccc2)c2c1[N+]([O-])=O Chemical compound Cc(cc1)c(cccc2)c2c1[N+]([O-])=O FRLVKAJKOYFHKQ-UHFFFAOYSA-N 0.000 description 1
- RNIIVXCSQPGXAF-UHFFFAOYSA-N Nc(cc1)cc(N2)c1SC2=O Chemical compound Nc(cc1)cc(N2)c1SC2=O RNIIVXCSQPGXAF-UHFFFAOYSA-N 0.000 description 1
- YYHDFTZIXPBRED-UYNZEQDHSA-N O=C(CC(C1)[C@@H](C2)C2C1C1)N(c2cc(Cl)cc(Cl)c2)C1=O Chemical compound O=C(CC(C1)[C@@H](C2)C2C1C1)N(c2cc(Cl)cc(Cl)c2)C1=O YYHDFTZIXPBRED-UYNZEQDHSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002439265A CA2439265A1 (en) | 2001-02-27 | 2002-02-20 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
JP2002567306A JP2004523558A (ja) | 2001-02-27 | 2002-02-20 | 縮合環式スクシンイミド化合物およびその類似体、核内ホルモン受容体機能のモジュレーター |
EP02719057A EP1379249A4 (en) | 2001-02-27 | 2002-02-20 | Attached Cytic Succinimide Compounds and Analogs Thereof, Nuclear Hormone Regenerative Function Modulators |
HU0304055A HUP0304055A2 (hu) | 2001-02-27 | 2002-02-20 | Kondenzált heterociklusos szukcinimid-vegyületek és analógjaik és alkalmazásuk nukleáris hormon receptor funkció modulátoraiként |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27167201P | 2001-02-27 | 2001-02-27 | |
US60/271,672 | 2001-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002067939A1 true WO2002067939A1 (en) | 2002-09-06 |
Family
ID=23036570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/005302 WO2002067939A1 (en) | 2001-02-27 | 2002-02-20 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
Country Status (6)
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004007461A1 (en) * | 2002-07-16 | 2004-01-22 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
WO2005035512A1 (ja) * | 2003-10-10 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン誘導体 |
EP1638938A2 (en) * | 2003-06-20 | 2006-03-29 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US7759371B2 (en) | 2001-12-11 | 2010-07-20 | Kyowa Hakko Kinn Co., Ltd. | Thiadiazoline derivative |
US7851635B2 (en) | 2003-04-18 | 2010-12-14 | Kyowa Hakko Kirin Co., Ltd. | Mitotic kinesin inhibitor |
WO2011007819A1 (ja) | 2009-07-17 | 2011-01-20 | 塩野義製薬株式会社 | ラクタムまたはベンゼンスルホンアミド化合物を含有する医薬 |
US7910611B2 (en) | 2005-06-24 | 2011-03-22 | Kyowa Hakko Kirin Co., Ltd. | Therapeutic agent for restenosis |
US7956197B2 (en) | 2003-06-20 | 2011-06-07 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US8039504B2 (en) | 2003-06-20 | 2011-10-18 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
AU2009243736B2 (en) * | 2008-05-06 | 2012-06-28 | Elexopharm Gmbh | 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CTP11B2 |
US8445491B2 (en) | 2008-05-27 | 2013-05-21 | The Board Of Regents Of The University Of Texas System | Wnt protein signalling inhibitors |
CN103193696A (zh) * | 2013-04-18 | 2013-07-10 | 北京大学 | 降冰片烯基酰亚胺体系甲壳型聚合物单体及其聚合物 |
US8530509B2 (en) | 2003-06-20 | 2013-09-10 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US9339466B2 (en) | 2010-03-23 | 2016-05-17 | Siga Technologies, Inc. | Polymorphic forms of ST-246 and methods of preparation |
WO2017186793A1 (en) * | 2016-04-27 | 2017-11-02 | Forschungsverbund Berlin E.V. | Antagonists of the thyroid-stimulating hormone receptor (tshr) |
CN110914240A (zh) * | 2015-11-30 | 2020-03-24 | 奥塔哥创新有限公司 | 释放一氧化碳的降冰片烯酮化合物 |
WO2023192782A3 (en) * | 2022-03-27 | 2023-11-09 | Board Of Regents, The University Of Texas System | Small molecule inhibitors of lanosterol synthase |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001911B2 (en) * | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
US20040077605A1 (en) * | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
EP1854798A3 (en) * | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
HUP0500096A3 (en) * | 2001-12-19 | 2012-08-28 | Bristol Myers Squibb Co | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function, process for producing them and pharmaceutical compositions containing them |
WO2004111024A1 (ja) * | 2003-06-10 | 2004-12-23 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン誘導体 |
US8426429B2 (en) * | 2004-08-06 | 2013-04-23 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
US8383637B2 (en) * | 2004-08-06 | 2013-02-26 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
US8436006B2 (en) * | 2004-08-06 | 2013-05-07 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
KR20070112775A (ko) * | 2005-01-10 | 2007-11-27 | 아카디아 파마슈티칼스 인코포레이티드 | 선택적인 안드로겐 수용체 조절자로서의 아미노페닐 유도체 |
US20080262049A1 (en) * | 2005-03-22 | 2008-10-23 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic Agent for Hematopoietic Tumor |
CN101193878A (zh) * | 2005-03-22 | 2008-06-04 | 协和发酵工业株式会社 | 实体肿瘤治疗剂 |
US7776882B2 (en) * | 2006-02-06 | 2010-08-17 | Baxter Ellen W | 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of β-secretase (BACE) |
US7868022B2 (en) * | 2006-02-06 | 2011-01-11 | Janssen Pharmaceutica Nv | 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE) |
WO2007092839A2 (en) * | 2006-02-06 | 2007-08-16 | Janssen Pharmaceutica N.V. | Macrocycle derivatives useful as inhibitors of beta-secretase (bace) |
US7468439B2 (en) * | 2006-09-06 | 2008-12-23 | Bristol-Myers Squibb Company | Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function |
US8466171B2 (en) * | 2007-11-01 | 2013-06-18 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
CN101925578B (zh) * | 2008-01-28 | 2012-11-28 | 詹森药业有限公司 | 可用作β-分泌酶(BACE)抑制剂的6-取代-硫代-2-氨基-喹啉衍生物 |
JP2011510993A (ja) * | 2008-01-29 | 2011-04-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | β−セクレターゼ(BACE)阻害剤として有用な2−アミノ−キノリン誘導体 |
EP2735567B1 (en) * | 2011-07-21 | 2016-10-26 | Xuanzhu Pharma Co., Ltd. | Heterocyclic substituted pyrimidine compound |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
GB201507937D0 (en) * | 2015-05-08 | 2015-06-24 | Univ Hertfordshire Higher Education Corp | Compounds for treatment of pancreatic cancer |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CN106349160B (zh) * | 2016-08-05 | 2019-07-26 | 浙江工业大学 | 一种8-氨基喹啉衍生物及其制备与应用 |
CN107954992A (zh) * | 2017-12-15 | 2018-04-24 | 田元强 | 吡咯二酮衍生物及其在小菜蛾和桃蚜防治中的应用 |
CN110183456A (zh) * | 2019-07-11 | 2019-08-30 | 河南师范大学 | 一种2-芳基吲唑琥珀酰亚胺螺环化合物的合成方法 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN115340483A (zh) * | 2022-08-31 | 2022-11-15 | 南京吉星生物技术开发有限公司 | 一种萘基吡咯啉二酮化合物及其制备方法与它的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532372A (en) * | 1990-07-06 | 1996-07-02 | Sumitomo Pharmaceuticals Company, Ltd. | Imide derivatives, and their production and use |
WO1999032463A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
Family Cites Families (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3320270A (en) | 1963-10-08 | 1967-05-16 | Tri Kem Corp | Certain 2-acylimidothiazole compounds |
US3215597A (en) | 1963-10-30 | 1965-11-02 | Dow Chemical Co | Methods and compositions for use in animal husbandry |
US3343940A (en) | 1964-06-12 | 1967-09-26 | Pennsalt Chemicals Corp | Process for plant desiccation |
US3261845A (en) | 1964-07-14 | 1966-07-19 | Dow Chemical Co | N-phenyl derivatives of 3,6-epoxyhexahydrophthalimide |
GB1039020A (en) | 1964-09-21 | 1966-08-17 | Biorex Laboratories Ltd | Process for the preparation of 5-nitrofurfuraldehyde diacetate |
US3428538A (en) | 1966-01-13 | 1969-02-18 | Peter Scheiner | Method for preparing aziridines by photolysis of triazolines |
JPS4916937B1 (US07655688-20100202-C00010.png) | 1970-01-21 | 1974-04-25 | ||
US3998833A (en) | 1971-12-20 | 1976-12-21 | Petrolite Corporation | Diels-alder adducts of dihydro-nitrogen heterocyclic phosphoramidates |
US3821232A (en) | 1971-12-20 | 1974-06-28 | Petrolite Corp | 1,2-dihydro-pyridine-n-phosphonates and thiophosphonates |
US3923490A (en) | 1971-12-20 | 1975-12-02 | Petrolite Corp | Use of 1,2-dihydro-pyridine-N-phosphonates and thiophosphonates as microbiocides |
US4089650A (en) | 1971-12-20 | 1978-05-16 | Petrolite Corporation | Use of Diels-Alder adducts of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors |
US3965264A (en) | 1971-12-20 | 1976-06-22 | Petrolite Corporation | Process for controlling microbiological organisms in aqueous or petroleum hydrocarbon systems |
JPS5032306B2 (US07655688-20100202-C00010.png) | 1972-11-02 | 1975-10-20 | ||
US3925554A (en) | 1972-11-30 | 1975-12-09 | Sumitomo Chemical Co | Certain 3,5-dichlorophenyl compound used as a plant fungicide |
NL7501563A (nl) | 1974-02-28 | 1975-09-01 | Merck & Co Inc | Werkwijze voor het bereiden van preparaten te- gen het samenpakken van bloedplaatjes. |
US3997293A (en) | 1974-03-19 | 1976-12-14 | Petrolite Corporation | Use of dihydro-nitrogen heterocyclic phosphoramidates as corrosion inhibitors |
FR2329276A1 (fr) | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
EP0002309B1 (en) | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
CA1138334A (en) | 1977-10-28 | 1982-12-28 | Karl Bernauer | Pharmaceutical preparations containing certain urea derivatives |
MC1220A1 (fr) | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
US4191775A (en) | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
FR2465486A1 (fr) | 1979-09-21 | 1981-03-27 | Roussel Uclaf | Nouvelle application utilisant la lh-rh ou des agonistes |
FR2492381A1 (fr) | 1980-10-21 | 1982-04-23 | Science Union & Cie | Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
DE3121152A1 (de) | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
US4753957A (en) | 1981-09-28 | 1988-06-28 | Rohm And Haas Company | Substituted 2,4-imidazolidinediones and fungicidal compositions |
US5645925A (en) | 1988-03-14 | 1997-07-08 | Boeing Company | Advanced composite blends |
US4536559A (en) | 1983-06-17 | 1985-08-20 | The Boeing Company | Thermally stable polyimide polysulfone compositions for composite structures |
US5116935A (en) | 1987-05-04 | 1992-05-26 | The Boeing Company | Polyimide oligomers and blends and method of curing |
US5446120A (en) | 1985-10-07 | 1995-08-29 | The Boeing Company | Polyethersulfone oligomers and blends |
US5693741A (en) | 1988-03-15 | 1997-12-02 | The Boeing Company | Liquid molding compounds |
US5367083A (en) | 1987-09-03 | 1994-11-22 | The Boeing Company | Extended acid halide capping monomers |
US5155206A (en) | 1987-09-03 | 1992-10-13 | The Boeing Company | Crosslinkable polyamideimide oligomers and a method of preparation |
US4851495A (en) | 1987-02-20 | 1989-07-25 | The Boeing Company | Polyetherimide oligomer |
US5516876A (en) | 1983-09-27 | 1996-05-14 | The Boeing Company | Polyimide oligomers and blends |
US4584364A (en) | 1984-02-06 | 1986-04-22 | The Boeing Company | Phenolic-capped imide sulfone resins |
US5512676A (en) | 1987-09-03 | 1996-04-30 | The Boeing Company | Extended amideimide hub for multidimensional oligomers |
US5210213A (en) | 1983-06-17 | 1993-05-11 | The Boeing Company | Dimensional, crosslinkable oligomers |
US5780583A (en) | 1991-01-09 | 1998-07-14 | The Boeing Company | Reactive polyarylene sulfide oligomers |
US5286811A (en) | 1983-09-27 | 1994-02-15 | The Boeing Company | Blended polyimide oligomers and method of curing polyimides |
US5104967A (en) | 1987-09-03 | 1992-04-14 | The Boeing Company | Amideimide oligomers and blends |
US4507303A (en) | 1981-12-22 | 1985-03-26 | Sumitomo Chemical Company, Limited | Succinimide derivatives, compositions and method of use |
EP0091596B1 (de) | 1982-04-08 | 1991-09-11 | Shell Internationale Researchmaatschappij B.V. | Neue Hydantoine, ihre Herstellung und Verwendung |
DE3227055A1 (de) | 1982-07-20 | 1984-01-26 | Hoechst Ag, 6230 Frankfurt | Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung |
US4473393A (en) | 1982-08-06 | 1984-09-25 | Buffalo Color Corporation | Pesticidal thiohydantoin compositions |
JPS59118750A (ja) | 1982-12-27 | 1984-07-09 | Eisai Co Ltd | カルボン酸アミド化合物およびその誘導体 |
US5112939A (en) | 1983-06-17 | 1992-05-12 | The Boeing Company | Oligomers having pyrimidinyl end caps |
US4980481A (en) | 1983-06-17 | 1990-12-25 | The Boeing Company | End-cap monomers and oligomers |
US4476184A (en) | 1983-08-09 | 1984-10-09 | The Boeing Company | Thermally stable polysulfone compositions for composite structures |
US4582886A (en) | 1984-02-27 | 1986-04-15 | General Electric Company | Heat curable epoxy resin compositions and epoxy resin curing agents |
US4562255A (en) | 1984-03-30 | 1985-12-31 | American Home Products Corporation | Substituted bi-alicyclic imides |
US4533737A (en) | 1984-04-02 | 1985-08-06 | General Electric Company | Silicon functionalized norbornane carboxyimide and methods for making |
GB8411928D0 (en) | 1984-05-10 | 1984-06-13 | Robinson Bros Ltd | Preparing substituted oxazolines |
US4775660A (en) | 1984-08-02 | 1988-10-04 | Fernand Labrie | Treatment of breast cancer by combination therapy |
US4760053A (en) | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
US4659695A (en) | 1985-02-08 | 1987-04-21 | Fernand Labrie | Method of treatment of prostate cancer |
US4666885A (en) | 1985-02-08 | 1987-05-19 | Fernand Labrie | Combination therapy for treatment of female breast cancer |
US4670536A (en) | 1985-06-01 | 1987-06-02 | Director-General Of Agency Of Industrial Science And Technology | Addition-curable quinoxaline resin oligomer and intermediate material for fiber-reinforced composite |
US4656235A (en) | 1985-09-05 | 1987-04-07 | Polytechnic Institute Of New York | Siloxane-containing polyimide coatings for electronic devices |
US5594089A (en) | 1985-09-05 | 1997-01-14 | The Boeing Company | Heterocycle or heterocycle sulfone oligomers with multiple chemically functional end caps |
US5610317A (en) | 1985-09-05 | 1997-03-11 | The Boeing Company | Multiple chemically functional end cap monomers |
US5151487A (en) | 1985-09-30 | 1992-09-29 | The Boeing Company | Method of preparing a crosslinking oligomer |
US4892943A (en) | 1985-10-16 | 1990-01-09 | American Home Products Corporation | Fused bicyclic imides with psychotropic activity |
GB8617653D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
US5084472A (en) | 1986-11-04 | 1992-01-28 | Roussel | Application of 1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4'-dimethylimidazoline 2,5-dione in the treatment of hormone-dependent cancers other than that of the prostate |
FR2619381B1 (fr) | 1987-08-13 | 1989-12-08 | Roussel Uclaf | Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation |
US4892578A (en) | 1987-11-06 | 1990-01-09 | Fmc Corporation | Phenylmethyl-4,4-dimethyl-3-isoxazolidinone plant regulators |
US5817744A (en) | 1988-03-14 | 1998-10-06 | The Boeing Company | Phenylethynyl capped imides |
US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
IE62715B1 (en) | 1989-03-10 | 1995-02-22 | Endorecherche Inc | Combination therapy for treatment of estrogen sensitive diseases |
FR2649110B1 (fr) | 1989-06-29 | 1994-10-21 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ATE269066T1 (de) | 1989-07-07 | 2004-07-15 | Endorech Inc | Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie |
FR2656302B1 (fr) | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
US5114612A (en) | 1990-04-04 | 1992-05-19 | The United States Of America As Represented By The Department Of Energy | Liquid crystal polyester thermosets |
US5093500A (en) | 1990-10-17 | 1992-03-03 | Shell Oil Company | Spirodilactam bisimides |
HUT62296A (en) | 1990-12-18 | 1993-04-28 | Sandoz Ag | Herbicidal composition comprising hydantoin derivative as active ingredient and process for producing the active ingredient |
FR2671348B1 (fr) | 1991-01-09 | 1993-03-26 | Roussel Uclaf | Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
USRE35956E (en) | 1991-01-09 | 1998-11-10 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
US5411981A (en) | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2694290B1 (fr) | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
IL107719A0 (en) | 1992-12-21 | 1994-02-27 | Du Pont | Imidazolones their manufacture and their use as herbicides |
DK0611885T3 (US07655688-20100202-C00010.png) | 1993-02-17 | 1997-06-30 | New Sulzer Diesel Ag | |
US5399725A (en) | 1993-05-27 | 1995-03-21 | Bristol-Myers Squibb Co. | 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same |
TW521073B (en) | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
FR2716110B1 (fr) | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Compositions cosmétiques ou pharmaceutiques comprenant des liposomes. |
US5539126A (en) | 1994-04-20 | 1996-07-23 | Bristol-Myers Squibb Company | Method for preparing homochiral maleimide intermediates, via silylation techniques |
GB9411800D0 (en) | 1994-06-13 | 1994-08-03 | Sandoz Ltd | Organic compounds |
EP0777458B1 (en) | 1994-09-14 | 2000-12-06 | Central Sheffield University Hospitals NHS Trust | Control of hair growth |
FR2742749B1 (fr) | 1995-12-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques |
US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
US6017924A (en) * | 1996-06-27 | 2000-01-25 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
AU4723197A (en) | 1996-10-25 | 1998-05-22 | Daiichi Pharmaceutical Co., Ltd. | Tricyclic amine derivatives |
US6071957A (en) | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
US5929146A (en) | 1996-12-27 | 1999-07-27 | Minnesota Mining And Manufacturing Company | Modifying agents for polyolefins |
FR2764890B1 (fr) | 1997-06-24 | 1999-08-27 | Adir | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1268137A (zh) | 1997-07-03 | 2000-09-27 | 杜邦药品公司 | 治疗神经失调的咪唑并嘧啶和咪唑并吡啶 |
CA2301780A1 (en) | 1997-08-28 | 1999-03-04 | Janus Pharmaceuticals, Inc. | Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition |
WO2000013508A1 (en) | 1998-09-09 | 2000-03-16 | Ishihara Sangyo Kaisha, Ltd. | Fused-benzene derivatives useful as herbicides |
US6297380B1 (en) | 1998-11-23 | 2001-10-02 | Pfizer Inc. | Process and intermediates for growth hormone secretagogues |
DE69909947T2 (de) | 1998-12-02 | 2004-02-12 | Nippon Paper Industries Co. Ltd. | Tintenstrahlaufzeichnungsblatt mit einer Bildschutzschicht |
JP2000169474A (ja) | 1998-12-07 | 2000-06-20 | Kotobuki Seiyaku Kk | イソキヌクリジン誘導体及びその製造方法並びにこれを含有する高コレステロール血症治療剤 |
AU1928800A (en) | 1998-12-22 | 2000-07-12 | Eli Lilly And Company | Substituted tricyclics |
DK1140941T3 (da) | 1998-12-23 | 2005-02-14 | Bristol Myers Squibb Pharma Co | Nitrogenholdige heterobicykliske forbindelser som faktor Xa-inhibitorer |
GB9918962D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
GB9921150D0 (en) | 1999-09-07 | 1999-11-10 | Merck Sharp & Dohme | Therapeutic agents |
SK286788B6 (sk) | 1999-10-08 | 2009-05-07 | Grnenthal Gmbh | Bicyklické deriváty imidazo-3-yl-amínu, spôsob ich výroby, ich použitie a liečivá obsahujúce tieto látky |
US6200573B1 (en) | 1999-12-03 | 2001-03-13 | Starcor Pharmaceuticals, Inc. | Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
US6403588B1 (en) | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
US7001911B2 (en) * | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
US20040077605A1 (en) | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
EP1299094A2 (en) * | 2000-06-28 | 2003-04-09 | Bristol-Myers Squibb Company | Selective androgen receptor modulators and methods for their identification, design and use |
US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
AU6994301A (en) | 2000-09-19 | 2002-04-02 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
CA2423050A1 (en) | 2000-09-20 | 2002-03-28 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazine derivatives as modulators of tyrosine kinases |
US6545017B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Urea substituted imidazopyridines |
FR2818277B1 (fr) | 2000-12-14 | 2003-01-24 | Servier Lab | Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ATE323701T1 (de) | 2001-03-09 | 2006-05-15 | Pfizer Prod Inc | Triazolopyridine als entzündungshemmende mittel |
WO2002085356A1 (en) | 2001-04-18 | 2002-10-31 | Bristol-Myers Squibb Company | 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors |
WO2003011824A1 (en) | 2001-07-31 | 2003-02-13 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
HUP0500096A3 (en) * | 2001-12-19 | 2012-08-28 | Bristol Myers Squibb Co | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function, process for producing them and pharmaceutical compositions containing them |
TW200407324A (en) * | 2002-05-17 | 2004-05-16 | Bristol Myers Squibb Co | Bicyclic modulators of androgen receptor function |
US7405234B2 (en) * | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
EP1534707B9 (en) | 2002-06-19 | 2008-11-26 | Janssen Pharmaceutica N.V. | Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
-
2002
- 2002-02-14 US US10/075,870 patent/US20040087548A1/en not_active Abandoned
- 2002-02-20 JP JP2002567306A patent/JP2004523558A/ja not_active Withdrawn
- 2002-02-20 WO PCT/US2002/005302 patent/WO2002067939A1/en active Application Filing
- 2002-02-20 EP EP02719057A patent/EP1379249A4/en not_active Withdrawn
- 2002-02-20 CA CA002439265A patent/CA2439265A1/en not_active Abandoned
- 2002-02-20 HU HU0304055A patent/HUP0304055A2/hu unknown
-
2005
- 2005-12-19 US US11/311,731 patent/US7655688B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532372A (en) * | 1990-07-06 | 1996-07-02 | Sumitomo Pharmaceuticals Company, Ltd. | Imide derivatives, and their production and use |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
WO1999032463A1 (en) * | 1997-12-22 | 1999-07-01 | Bayer Corporation | INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
Non-Patent Citations (1)
Title |
---|
See also references of EP1379249A4 * |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759371B2 (en) | 2001-12-11 | 2010-07-20 | Kyowa Hakko Kinn Co., Ltd. | Thiadiazoline derivative |
US7902234B2 (en) | 2001-12-11 | 2011-03-08 | Kyowa Hakko Kirin Co., Ltd. | Thiadiazoline derivative |
US9302993B2 (en) | 2002-07-16 | 2016-04-05 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
WO2004007461A1 (en) * | 2002-07-16 | 2004-01-22 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
US9169211B2 (en) | 2002-07-16 | 2015-10-27 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
US8975278B2 (en) | 2002-07-16 | 2015-03-10 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
US7619091B2 (en) | 2002-07-16 | 2009-11-17 | Prana Biotechnology Limited | 8-hydroxy quinoline derivatives |
US7851635B2 (en) | 2003-04-18 | 2010-12-14 | Kyowa Hakko Kirin Co., Ltd. | Mitotic kinesin inhibitor |
US8318782B2 (en) | 2003-04-18 | 2012-11-27 | Kyowa Hakko Kirin Co., Ltd. | Mitotic kinesin inhibitor |
US8039504B2 (en) | 2003-06-20 | 2011-10-18 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
EP1638938B1 (en) * | 2003-06-20 | 2017-04-12 | Siga Technologies Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
AU2004249250B2 (en) * | 2003-06-20 | 2011-09-01 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
EP1638938A2 (en) * | 2003-06-20 | 2006-03-29 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US8124643B2 (en) | 2003-06-20 | 2012-02-28 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
AU2004249250C1 (en) * | 2003-06-20 | 2012-04-12 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US9045418B2 (en) | 2003-06-20 | 2015-06-02 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of Orthopoxvirus infections and associated diseases |
JP2007521273A (ja) * | 2003-06-20 | 2007-08-02 | シガ テクノロジーズ,インコーポレーテッド | オルトポックスウイルス感染及び関連疾患を治療及び予防するための化合物、組成物及び方法 |
US8802714B2 (en) | 2003-06-20 | 2014-08-12 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US7956197B2 (en) | 2003-06-20 | 2011-06-07 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
US8530509B2 (en) | 2003-06-20 | 2013-09-10 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
WO2005035512A1 (ja) * | 2003-10-10 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | チアジアゾリン誘導体 |
US7910611B2 (en) | 2005-06-24 | 2011-03-22 | Kyowa Hakko Kirin Co., Ltd. | Therapeutic agent for restenosis |
AU2009243736B2 (en) * | 2008-05-06 | 2012-06-28 | Elexopharm Gmbh | 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CTP11B2 |
US8445491B2 (en) | 2008-05-27 | 2013-05-21 | The Board Of Regents Of The University Of Texas System | Wnt protein signalling inhibitors |
US9045416B2 (en) | 2008-05-27 | 2015-06-02 | The Board Of Regents Of The University Of Texas System | WNT protein signalling inhibitors |
WO2011007819A1 (ja) | 2009-07-17 | 2011-01-20 | 塩野義製薬株式会社 | ラクタムまたはベンゼンスルホンアミド化合物を含有する医薬 |
US9339466B2 (en) | 2010-03-23 | 2016-05-17 | Siga Technologies, Inc. | Polymorphic forms of ST-246 and methods of preparation |
US9744154B2 (en) | 2010-03-23 | 2017-08-29 | Siga Technologies, Inc. | Polymorphic forms of ST-246 and methods of preparation |
US10045964B2 (en) | 2010-03-23 | 2018-08-14 | Siga Technologies Inc. | Polymorphic forms of ST-246 and methods of preparation |
US10406137B2 (en) | 2010-03-23 | 2019-09-10 | Siga Technologies Inc. | Polymorphic forms of ST-246 and methods of preparation |
US10933050B2 (en) | 2010-03-23 | 2021-03-02 | Siga Technologies Inc. | Polymorphic forms of ST-246 and methods of preparation |
US11890270B2 (en) | 2010-03-23 | 2024-02-06 | Siga Technologies, Inc. | Polymorphic forms of ST-246 and methods of preparation |
CN103193696B (zh) * | 2013-04-18 | 2015-11-11 | 北京大学 | 降冰片烯基酰亚胺体系甲壳型聚合物单体及其聚合物 |
CN103193696A (zh) * | 2013-04-18 | 2013-07-10 | 北京大学 | 降冰片烯基酰亚胺体系甲壳型聚合物单体及其聚合物 |
CN110914240A (zh) * | 2015-11-30 | 2020-03-24 | 奥塔哥创新有限公司 | 释放一氧化碳的降冰片烯酮化合物 |
CN110914240B (zh) * | 2015-11-30 | 2024-02-20 | 奥塔哥创新有限公司 | 释放一氧化碳的降冰片烯酮化合物 |
WO2017186793A1 (en) * | 2016-04-27 | 2017-11-02 | Forschungsverbund Berlin E.V. | Antagonists of the thyroid-stimulating hormone receptor (tshr) |
US10596168B2 (en) | 2016-04-27 | 2020-03-24 | Forschungsverbund Berlin E.V. | Antagonists of the thyroid-stimulating hormone receptor (TSHR) |
WO2023192782A3 (en) * | 2022-03-27 | 2023-11-09 | Board Of Regents, The University Of Texas System | Small molecule inhibitors of lanosterol synthase |
Also Published As
Publication number | Publication date |
---|---|
CA2439265A1 (en) | 2002-09-06 |
HUP0304055A2 (hu) | 2004-04-28 |
EP1379249A1 (en) | 2004-01-14 |
US20060111424A1 (en) | 2006-05-25 |
EP1379249A4 (en) | 2008-01-09 |
JP2004523558A (ja) | 2004-08-05 |
US20040087548A1 (en) | 2004-05-06 |
US7655688B2 (en) | 2010-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7655688B2 (en) | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
EP1467979B1 (en) | Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function | |
AU2001269943B2 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
US7235563B2 (en) | Spirocyclic compounds useful as modulators of nuclear hormone receptor function | |
EP1458723B1 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
US7550458B2 (en) | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function | |
US20080214643A1 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
AU2001269943A1 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
WO2005040136A1 (en) | Piperazine derivatives and their use as modulators of nuclear hormone receptor function | |
AU2002250163A1 (en) | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
RU2298554C2 (ru) | Конденсированные гетероциклические сукцинимидные соединения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2439265 Country of ref document: CA Ref document number: 2002250163 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002719057 Country of ref document: EP Ref document number: 2002567306 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2002719057 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |